Nanofiber Therapeutics: Revolutionizing Cancer and Inflammation Management

Neeraj Mishra · Goutam Rath · Arun Kumar Singh

ጃን 2026 · Academic Press

ኢ-መጽሐፍ

320

ገጾች

ብቁ

ይህ መጽሐፍ በ1 ጃንዋሪ 2026 ላይ የሚገኝ ይሆናል። እስከሚለቀቅ ድረስ ክፍያ እንዲከፍሉ አይጠየቁም።

ስለዚህ ኢ-መጽሐፍ

Nanofiber Therapeutics: Revolutionizing Cancer and Inflammation Management is a comprehensive resource designed to enrich knowledge, catalyze scientific advancements, empower patients, and inform policy decisions in nanomedicine. This book leverages the transformative potential of nanotechnology to combat cancer and inflammation, two of the most challenging health conditions today. The book explores the revolutionary potential of nanofiber-based therapeutics, aiming to develop innovative solutions that overcome existing treatment limitations and improve patient outcomes. It bridges the gap between basic scientific research and clinical application, synthesizing the latest advancements in nanofiber technology with insights from preclinical and clinical studies. Covering every facet of nanofiber therapies—from design and production to clinical applications—the book offers a comprehensive overview. It aims to educate healthcare professionals, researchers, policymakers, patients, and the public about the potential of nanofiber therapeutics, empowering stakeholders with the knowledge needed for informed decision-making and interdisciplinary collaboration. By highlighting cutting-edge research and technological innovations, this book inspires scientific curiosity and further research in the field. It fills a gap in the existing literature, laying the groundwork for future research and development, and driving advancements that could transform cancer and inflammation treatment. - Provides a thorough examination of nanofiber therapies, encompassing design, production, and clinical applications in the treatment of inflammation and cancer - Presents the most recent developments and studies in nanofiber therapeutics, including novel approaches to drug delivery and advancements in nanofiber technology - Offers insights into how nanofiber technologies can augment existing treatment approaches and improve patient outcomes

ስለደራሲው

Dr. Neeraj Mishra is a Professor and Head of the Department of Pharmaceutics at Amity Institute of Pharmacy, India, a position he has held since July 2019. With nearly two decades of teaching and research experience, Dr. Mishra has authored over 100 publications on novel drug delivery systems, focusing on nanocarriers and microparticles for treating breast and colon cancer, as well as neurodegenerative disorders. He has written several books and book chapters, and holds three international and two Indian patents. Dr. Mishra has received numerous accolades, including the "Distinguished Professor Award" (2019, 2021) and the "Outstanding Scientist Award" (2020). He has served as a guest editor for Bentham Sciences and is recognized in Stanford University's World Scientists Rankings for 2022 and 2024.

Prof. Rath's research interests include probiotics, immunology, novel drug delivery systems, and targeted bio-active delivery in the treatment of cancer, and infectious disorders. Recently Dr. Rath was recognized as the world's top 2 % scientist published by Stanford University, USA in the years 2019-2023. He is also the recipient of the Top 10 Scientist of India by Carrier 360 in the year 2018 and the best innovator by NRDC. He serves on various expert/reviewer panels in the areas of medical biotechnology, drug delivery, tissue engineering, and nanotechnology. He has published more than 170 scientific articles in recognized journals and authored four textbooks in the field of pharmaceutical and nanosciences.

Arun Kumar Singh earned his M. Pharm in Pharmaceutics from Galgotias University and currently serves as an Assistant Professor at the Amity Institute of Pharmacy, Amity University, Greater Noida. With over a decade of experience teaching pharmacology-related courses, Professor Singh has cultivated a diverse range of research interests, including nano-formulation, blockchain, IoT, machine learning, cancer, artificial intelligence, big data, and neuroscience. He has authored 5 book chapters, edited multiple books with notable international publishers, and has published 24 review papers, including two in the prestigious Biochimica et Biophysica Acta (BBA) – Reviews on Cancer. Renowned for his research acumen, innovative thinking, leadership, and positive outlook, Professor Singh's dedication and hard work have distinguished him as a leading figure in his field.